PRKAA1 and fragile X-associated tremor/ataxia syndrome: Questions about the mechanism by which AMPK is dramatically elevated in the non-FXTAS carriers compared with healthy controls and normalizes in the fully syndromic FXTAS group should be explored in larger samples, including all three clinical groups, as distinguished here, in a longitudinal study.